Ulisse Biomed S.p.A. (UBM.MI)

EUR 0.78

(0.0%)

Operating Expenses Summary of Ulisse Biomed S.p.A.

Ulisse Biomed S.p.A.'s latest annual operating expenses in 2023 was 1.91 Million EUR , up 86.45% from previous year.
Ulisse Biomed S.p.A.'s latest quarterly operating expenses in 2024 Q1 was 623.14 Thousand EUR , down -23.76% from previous quarter.
Ulisse Biomed S.p.A. reported a annual operating expenses of 156.08 Thousand EUR in annual operating expenses 2022, up 93.65% from previous year.
Ulisse Biomed S.p.A. reported a annual operating expenses of 80.6 Thousand EUR in annual operating expenses 2021, up 0.75% from previous year.
Ulisse Biomed S.p.A. reported a quarterly operating expenses of 623.14 Thousand EUR for 2024 Q1, down -23.76% from previous quarter.
Ulisse Biomed S.p.A. reported a quarterly operating expenses of 291.01 Thousand EUR for 2023 FY, up 86.45% from previous quarter.

Annual Operating Expenses Chart of Ulisse Biomed S.p.A. (2023 - 2018)

Historical Annual Operating Expenses of Ulisse Biomed S.p.A. (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	1.91 Million EUR	86.45%
2022	156.08 Thousand EUR	93.65%
2021	80.6 Thousand EUR	0.75%
2020	80 Thousand EUR	-80.82%
2019	417 Thousand EUR	-77.04%
2018	1.81 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	623.14 Thousand EUR	0.0%
2024 Q1	623.14 Thousand EUR	-23.76%
2023 FY	291.01 Thousand EUR	86.45%
2023 Q3	1.42 Million EUR	1455.61%
2023 Q4	817.33 Thousand EUR	-42.78%
2023 Q2	91.81 Thousand EUR	-53.06%
2023 Q1	195.62 Thousand EUR	152.97%
2022 Q2	78.75 Thousand EUR	63.26%
2022 FY	156.08 Thousand EUR	93.65%
2022 Q3	158.18 Thousand EUR	100.85%
2022 Q1	48.24 Thousand EUR	19.43%
2022 Q4	77.32 Thousand EUR	-51.11%
2021 FY	80.6 Thousand EUR	0.75%
2021 Q1	57.26 Thousand EUR	25.44%
2021 Q2	40.21 Thousand EUR	-29.78%
2021 Q3	111.72 Thousand EUR	177.84%
2021 Q4	40.39 Thousand EUR	-63.85%
2020 Q2	31.34 Thousand EUR	758.14%
2020 FY	80 Thousand EUR	-80.82%
2020 Q3	44.65 Thousand EUR	42.45%
2020 Q1	3653.00 EUR	0.0%
2020 Q4	45.65 Thousand EUR	2.23%
2019 FY	417 Thousand EUR	-77.04%
2018 FY	1.81 Million EUR	0.0%

Peer Operating Expenses Comparison of Ulisse Biomed S.p.A.

Name	Operating Expenses	Operating Expenses Difference
ARTERRA BIOSCIENCE	3.38 Million EUR	43.559%
Philogen S.p.A.	14.5 Million EUR	86.836%